We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cytoplasmic p53 Triggers Mitochondrial Apoptosis Pathway

By Biotechdaily staff writers
Posted on 24 Feb 2004
Researchers have found that cytoplasmic p53 tumor suppressor protein can cause cell death (apoptosis) by triggering a sequence of events that results in rupture of mitochondrial membranes.

Investigators at the La Jolla Institute for Allergy and Immunology (CA, USA; www.liai.org) used mouse embryonic fibroblasts growing in tissue culture to study the function of p53 located in the cytoplasm.

In their paper published in the February 13, 2004, issue of Science they reported that cytoplasmic p53 activated a different protein called Bax. More...
The Bax protein is a pro-apoptotic member of the Bcl-2 family of proteins that regulate the mitochondrial apoptosis pathway. Bax plays a pivotal role in the regulation of release of cell death-activating factors from mitochondria.

"We have discovered a new pathway for p53 to trigger the process that leads to cell death,” said senior author Dr. Douglas L. Green, a researcher at the La Jolla Institute for Allergy and Immunology. "This is another piece of the puzzle of how tumor cells are regulated and it could lead to better treatment for cancers and other diseases.”



Related Links:
La Jolla Institute for Allergy and Immunology

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.